Anders has more than 25 years of experience within international finance and business development from the pharmaceutical and medical device industries. His experience includes business and corporate development at Pharmacia & Upjohn, and Q-Med AB (publ) (today Galderma); partner and CEO at venture capital firm Nexttobe AB; and Executive VP and CFO at Oasmia Pharmaceutical AB (publ). In addition, Anders has extensive board experience from pharma- and technology sectors including, but not limited to, Hansa Biopharma AB (publ), Biolamina AB, Delta Projects AB, and Selego AB. Anders holds a BSc in Business Administration and Economics from Uppsala University.
Ongoing assignments: Chairman of the board of Maida Vale Capital AB, board member of Alzinova AB (publ), Hunterhex International Inc., Hunterhex AB, Wonderboo AB, Rosland Nordic AB and Challengehop Inc.
Independent in relation to the company and its management but not to major shareholders